Obstetrics

Pregnant women can safely take Claritin, study reports

Published in Women's Health Weekly, April 8th, 2004

Schering-Plough's widely used allergy drug Claritin (loratadine) does not cause genital birth defects in boys when taken by their mothers during early pregnancy, according to a study from the U.S. Centers for Disease Control and Prevention (CDC).

In a nationwide study, mothers who took Claritin were no more likely than other women to have boys with hypospadias, a defect in which the urethra opening is along the shaft of the penis, instead of at the tip.

The study contradicts Swedish research in 2002 that said Claritin use doubled the risk of having a boy with the defect.

"We do feel pretty confident there is no association between...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-04-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry